Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2021 16:54 ET | Source: Collegium Pharmaceutical, Inc.

UPDATE: Collegium to Participate in Upcoming Conferences

STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
November 11, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Participate in Upcoming Conferences

STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
November 04, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Reports Third Quarter Fiscal 2021 Results

- Board of Directors Has Authorized $25 Million Accelerated Share Repurchase Program -- Net Income of $8.0 Million and Adjusted EBITDA of $37.3 Million -- Full-Year 2021 Guidance Updated -- Conference...
October 21, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Host Conference Call to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update

STOUGHTON, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
September 13, 2021 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference

STOUGHTON, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
September 01, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
August 16, 2021 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces $100 Million Share Repurchase Program

STOUGHTON, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
August 05, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million

– Xtampza® ER Market Share Grew to 31.5% of the Oxycodone Extended-Release Market in June 2021 – – Net Income of $72.8 Million and Adjusted EBITDA of $40.1 Million – – Full-Year 2021 Product Revenue...
July 21, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Host Conference Call to Discuss Second Quarter 2021 Financial Results and Provide Corporate Update

STOUGHTON, Mass., July 21, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live webcast on Thursday, August 5,...
June 16, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces Publication of Real-World Data in Journal of Pain Research

STOUGHTON, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...